ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

RETROVIR IV
Viral infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

RETROVIR IV Rx

Generic Name and Formulations:
Zidovudine 10mg/mL; for IV infusion after dilution; preservative-free.

Company:
ViiV Healthcare

Therapeutic Use:

Indications for RETROVIR IV:

HIV infection, in combination with other antiretrovirals. Prevention of maternal-fetal HIV transmission.

Adult:

Give by IV infusion over 1hr; use only until oral therapy can be given. 1mg/kg every 4hrs. Renal impairment (CrCL <15mL/min) or on dialysis: 1mg/kg every 6–8hrs. Prevention of maternal-fetal HIV or vertical transmission, severe anemia and/or neutropenia: see full labeling.

Children:

Vertical transmission: see full labeling.

Warnings/Precautions:

Suspend if lactic acidosis or hepatotoxicity (eg, hepatomegaly and steatosis) occurs. Monitor for hematologic toxicity; reduce dose or suspend if significant anemia and/or granulocytopenia occurs; transfuse if necessary. Renal or hepatic dysfunction: consider reducing dose. Bone marrow suppression. Risk of liver disease. Women, obesity, prolonged nucleoside exposure, or advanced HIV disease: increased risk of toxicity. Monitor for lipoatrophy; if suspected, switch to alternative therapy. Latex allergy (IV). Elderly. Pregnancy. Nursing mothers: not recommended.

Interactions:

Avoid stavudine, doxorubicin, ribavirin, other nucleoside analogues. Caution with other cytotoxic or myelosuppressive drugs (eg, ganciclovir, interferon-alpha, ribavirin). Potentiated by fluconazole, atovaquone, lamivudine, probenecid, valproic acid, methadone. Monitor phenytoin. May be antagonized by clarithromycin, rifampin, ritonavir, nelfinavir. Monitor for treatment-associated toxicities with interferon-alpha with or without ribavirin.

See Also:

Zidovudine Tablets

RETROVIR CAPSULES

RETROVIR SYRUP

Pharmacological Class:

Nucleoside analogue (reverse transcriptase inhibitor).

Adverse Reactions:

Headache, malaise, nausea, vomiting, anorexia, insomnia, pain, myopathy, neuropathy, myositis, thrombocytopenia, anemia, neutropenia, lactic acidosis, steatosis, hepatomegaly, immune reconstitution syndrome, pancreatitis, others. Children: also fever, cough.

Note:

Register pregnant patients exposed to zidovudine by calling (800) 258-4263.

Generic Availability:

YES

How Supplied:

Tabs—contact supplier; Caps—100; Syrup—240mL; IV (20mL/vial)—10

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs